首页 > 最新文献

Advances in laboratory medicine最新文献

英文 中文
Caracterización genómica de los mecanismos de adaptación de Pseudomonas aeruginosa en pacientes con bronquiectasias. 支气管炎患者铜绿假单胞菌适应机制的基因组表征。
IF 1.1 Q4 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2025-12-08 eCollection Date: 2025-12-01 DOI: 10.1515/almed-2025-0173
Alba Muñoz Santa, Xavier Gómez-Arbonés, Ricardo Pifarré Teixidó, Mercè García-González, Alba Bellés Bellés
{"title":"Caracterización genómica de los mecanismos de adaptación de <i>Pseudomonas aeruginosa</i> en pacientes con bronquiectasias.","authors":"Alba Muñoz Santa, Xavier Gómez-Arbonés, Ricardo Pifarré Teixidó, Mercè García-González, Alba Bellés Bellés","doi":"10.1515/almed-2025-0173","DOIUrl":"10.1515/almed-2025-0173","url":null,"abstract":"","PeriodicalId":72097,"journal":{"name":"Advances in laboratory medicine","volume":"6 4","pages":"484-491"},"PeriodicalIF":1.1,"publicationDate":"2025-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12744366/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145859514","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aplicaciones y retos de ChatGPT en la medicina de laboratorio. ChatGPT在实验室医学中的应用和挑战。
IF 1.1 Q4 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2025-12-08 eCollection Date: 2025-12-01 DOI: 10.1515/almed-2025-0158
Zhili Niu, Xiandong Kuang, Juanjuan Chen, Xin Cai, Pingan Zhang
{"title":"Aplicaciones y retos de ChatGPT en la medicina de laboratorio.","authors":"Zhili Niu, Xiandong Kuang, Juanjuan Chen, Xin Cai, Pingan Zhang","doi":"10.1515/almed-2025-0158","DOIUrl":"10.1515/almed-2025-0158","url":null,"abstract":"","PeriodicalId":72097,"journal":{"name":"Advances in laboratory medicine","volume":"6 4","pages":"397-410"},"PeriodicalIF":1.1,"publicationDate":"2025-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12744373/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145859496","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmacogenetics and laboratory medicine: from individual genes towards integral genetic testing. 药物遗传学和检验医学:从个体基因到整体基因检测。
IF 1.1 Q4 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2025-12-05 eCollection Date: 2025-12-01 DOI: 10.1515/almed-2025-0182
Mercè Brunet Serra, María Isidoro-García
{"title":"Pharmacogenetics and laboratory medicine: from individual genes towards integral genetic testing.","authors":"Mercè Brunet Serra, María Isidoro-García","doi":"10.1515/almed-2025-0182","DOIUrl":"10.1515/almed-2025-0182","url":null,"abstract":"","PeriodicalId":72097,"journal":{"name":"Advances in laboratory medicine","volume":"6 4","pages":"377-380"},"PeriodicalIF":1.1,"publicationDate":"2025-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12744368/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145859591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A de novo variant of the COL3A1 gene: causality of vascular Ehlers-Danlos syndrome. COL3A1基因的新生变异:血管性埃勒-丹洛斯综合征的因果关系。
IF 1.1 Q4 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2025-11-26 eCollection Date: 2025-12-01 DOI: 10.1515/almed-2025-0172
Estrella Gutiérrez Romero, Nuria Padilla Apuntate, Silvia Izquierdo Álvarez

Objectives: To establish diagnosis of vascular Ehlers-Danlos syndrome (VEDS) through genetic testing. This syndrome is characterized by muscle and arterial ruptures and a tendency to easy brusing, thin skin with visible veins and acrogeric facial features that may be caused by pathogenic variants (PVs) in heterozygosis in the COL3A1 gene.

Case presentation: We present the case of a man who suffered a cerebrovascular accident. Following investigations, a de novo probably-pathogenic variant was identified in the COL3A1 gene, which directed initial suspicion from Marfan syndrome to a final diagnosis of VEDS.

Conclusions: The variant detected in the COL3A1 gene may support causality in the clinical context of this patient and contribute to improving therapeutic management in similar cases.

目的:建立血管性埃勒-丹洛斯综合征(VEDS)的基因检测诊断方法。这种综合征的特征是肌肉和动脉破裂,容易出现皱纹,皮肤薄,可见静脉,面部特征肥大,可能是由COL3A1基因杂合的致病性变异(pv)引起的。病例介绍:我们报告一位患脑血管意外的患者。经过调查,在COL3A1基因中发现了一种可能致病的新变异,这将最初的怀疑从马凡氏综合征转变为最终的VEDS诊断。结论:在COL3A1基因中检测到的变异可能支持该患者临床背景下的因果关系,并有助于改善类似病例的治疗管理。
{"title":"A <i>de novo</i> variant of the <i>COL3A1</i> gene: causality of vascular Ehlers-Danlos syndrome.","authors":"Estrella Gutiérrez Romero, Nuria Padilla Apuntate, Silvia Izquierdo Álvarez","doi":"10.1515/almed-2025-0172","DOIUrl":"10.1515/almed-2025-0172","url":null,"abstract":"<p><strong>Objectives: </strong>To establish diagnosis of vascular Ehlers-Danlos syndrome (VEDS) through genetic testing. This syndrome is characterized by muscle and arterial ruptures and a tendency to easy brusing, thin skin with visible veins and acrogeric facial features that may be caused by pathogenic variants (PVs) in heterozygosis in the <i>COL3A1</i> gene.</p><p><strong>Case presentation: </strong>We present the case of a man who suffered a cerebrovascular accident. Following investigations, a <i>de novo</i> probably-pathogenic variant was identified in the <i>COL3A1</i> gene, which directed initial suspicion from Marfan syndrome to a final diagnosis of VEDS.</p><p><strong>Conclusions: </strong>The variant detected in the <i>COL3A1</i> gene may support causality in the clinical context of this patient and contribute to improving therapeutic management in similar cases.</p>","PeriodicalId":72097,"journal":{"name":"Advances in laboratory medicine","volume":"6 4","pages":"500-503"},"PeriodicalIF":1.1,"publicationDate":"2025-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12744369/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145859511","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluación del diseño y costo-efectividad de un modelo de pruebas en el lugar de atención para mejorar la capacidad de resolución de las urgencias hospitalarias. 评估治疗现场检测模式的设计和成本效益,以提高医院急诊的解决能力。
IF 1.1 Q4 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2025-11-14 eCollection Date: 2025-12-01 DOI: 10.1515/almed-2025-0171
Marta Jimenez-Barragan, Antonio Leon-Justel, Catalina Sanchez-Mora
{"title":"Evaluación del diseño y costo-efectividad de un modelo de pruebas en el lugar de atención para mejorar la capacidad de resolución de las urgencias hospitalarias.","authors":"Marta Jimenez-Barragan, Antonio Leon-Justel, Catalina Sanchez-Mora","doi":"10.1515/almed-2025-0171","DOIUrl":"10.1515/almed-2025-0171","url":null,"abstract":"","PeriodicalId":72097,"journal":{"name":"Advances in laboratory medicine","volume":"6 4","pages":"467-476"},"PeriodicalIF":1.1,"publicationDate":"2025-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12744379/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145859487","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Más allá del volumen corpuscular medio: el papel del volumen de los neutrófilos y de los monocitos en el diagnóstico del déficit de B12 en pacientes con anemia. 超越平均体体积:中性粒细胞和单核细胞体积在贫血患者B12缺乏症诊断中的作用。
IF 1.1 Q4 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2025-11-13 eCollection Date: 2025-12-01 DOI: 10.1515/almed-2025-0163
Alba Leis-Sestayo, Álvaro Piedra-Aguilera, Laura Jiménez-Añón, Jennifer Rodríguez-Domínguez, Carme García-Martín, Alicia Martínez-Iribarren, Cristian Morales-Indiano
{"title":"Más allá del volumen corpuscular medio: el papel del volumen de los neutrófilos y de los monocitos en el diagnóstico del déficit de B12 en pacientes con anemia.","authors":"Alba Leis-Sestayo, Álvaro Piedra-Aguilera, Laura Jiménez-Añón, Jennifer Rodríguez-Domínguez, Carme García-Martín, Alicia Martínez-Iribarren, Cristian Morales-Indiano","doi":"10.1515/almed-2025-0163","DOIUrl":"10.1515/almed-2025-0163","url":null,"abstract":"","PeriodicalId":72097,"journal":{"name":"Advances in laboratory medicine","volume":"6 4","pages":"511-513"},"PeriodicalIF":1.1,"publicationDate":"2025-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12744370/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145859505","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Validación del reactivo fCAL turbo Buhlmann para la determinación de calprotectina en suero. fCAL Turbo Buhlmann反应物测定血清中钙蛋白酶的验证。
IF 1.1 Q4 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2025-11-12 eCollection Date: 2025-12-01 DOI: 10.1515/almed-2025-0174
Helena Čičak, Željka Šarčević, Ana Sruk, Frane Bukvić, Daria Pašalić, Lora Dukić, Ana-Maria Šimundić
{"title":"Validación del reactivo fCAL turbo Buhlmann para la determinación de calprotectina en suero.","authors":"Helena Čičak, Željka Šarčević, Ana Sruk, Frane Bukvić, Daria Pašalić, Lora Dukić, Ana-Maria Šimundić","doi":"10.1515/almed-2025-0174","DOIUrl":"10.1515/almed-2025-0174","url":null,"abstract":"","PeriodicalId":72097,"journal":{"name":"Advances in laboratory medicine","volume":"6 4","pages":"434-441"},"PeriodicalIF":1.1,"publicationDate":"2025-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12744376/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145859584","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Estudio comparativo de cuatro analizadores diferentes para la evaluación prenatal del riesgo de trisomía 21. 四种不同分析仪产前三体风险评估的比较研究。
IF 1.1 Q4 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2025-11-11 eCollection Date: 2025-12-01 DOI: 10.1515/almed-2025-0149
Natalia García-Simón, Cristina Martínez-Payo, Francisco A Bernabeu-Andreu, Encarnación Donoso-Navarro
{"title":"Estudio comparativo de cuatro analizadores diferentes para la evaluación prenatal del riesgo de trisomía 21.","authors":"Natalia García-Simón, Cristina Martínez-Payo, Francisco A Bernabeu-Andreu, Encarnación Donoso-Navarro","doi":"10.1515/almed-2025-0149","DOIUrl":"10.1515/almed-2025-0149","url":null,"abstract":"","PeriodicalId":72097,"journal":{"name":"Advances in laboratory medicine","volume":"6 4","pages":"419-426"},"PeriodicalIF":1.1,"publicationDate":"2025-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12744382/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145859450","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of the clinical laboratory in the study of mesalazine-induced nephrolithiasis and crystalluria. 临床实验室在美沙拉嗪所致肾结石和结晶尿研究中的作用。
IF 1.1 Q4 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2025-11-10 eCollection Date: 2025-12-01 DOI: 10.1515/almed-2025-0164
Ana Isabel Balbuena, Noelia Poveda, Araceli López, María José Ferri

Objectives: The development of urinary lithiasis is a relatively frequent complication in patients with inflammatory bowel disease (IBD). A multiplicity of factors - including medication - may induce the formation of renal stones and cause complications of variable severity.

Case presentation: We report a six-case series of patients with IBD treated with mesalazine who developed renoureteral colic. Spontaneous stone expulsion occurred in three patients, with infrared spectroscopy (IRS) confirming a composition of 100 % mesalazine. In the other three cases, the presence of crystalluria was confirmed in urine sediment during the renal colic. In two of these patients, IRS analysis of dried urine sediment confirmed a mesalazine composition.

Conclusions: The scarce literature available on the association between the use of mesalazine and increased risk of lithiasis fails to provide frequency data. Only a previous case on mesalazine crystalluria had been reported in the literature so far, probably due to the difficulty detecting this complication. This case series emphasizes the role of urine sediment analysis in identifying crystalluria and preventing major complications during the follow-up of patients receiving mesalazine therapy.

目的:尿路结石的发展是炎症性肠病(IBD)患者相对常见的并发症。多种因素——包括药物——可能诱发肾结石的形成并引起不同程度的并发症。病例介绍:我们报告了6例使用美沙拉嗪治疗的IBD患者并发肾绞痛。三名患者发生自发性结石排出,红外光谱(IRS)证实其成分为100% %美沙拉嗪。在其他三个病例中,在肾绞痛期间的尿沉淀物中证实了结晶尿的存在。在其中两名患者中,IRS对干燥尿液沉积物的分析证实了美沙拉嗪的成分。结论:关于使用美萨拉嗪与结石风险增加之间关系的文献很少,无法提供频率数据。到目前为止,文献中只报道了一例美沙拉嗪结晶尿,可能是由于难以发现这种并发症。本病例系列强调了在接受美沙拉嗪治疗的患者随访期间,尿沉渣分析在识别结晶尿和预防主要并发症中的作用。
{"title":"The role of the clinical laboratory in the study of mesalazine-induced nephrolithiasis and crystalluria.","authors":"Ana Isabel Balbuena, Noelia Poveda, Araceli López, María José Ferri","doi":"10.1515/almed-2025-0164","DOIUrl":"10.1515/almed-2025-0164","url":null,"abstract":"<p><strong>Objectives: </strong>The development of urinary lithiasis is a relatively frequent complication in patients with inflammatory bowel disease (IBD). A multiplicity of factors - including medication - may induce the formation of renal stones and cause complications of variable severity.</p><p><strong>Case presentation: </strong>We report a six-case series of patients with IBD treated with mesalazine who developed renoureteral colic. Spontaneous stone expulsion occurred in three patients, with infrared spectroscopy (IRS) confirming a composition of 100 % mesalazine. In the other three cases, the presence of crystalluria was confirmed in urine sediment during the renal colic. In two of these patients, IRS analysis of dried urine sediment confirmed a mesalazine composition.</p><p><strong>Conclusions: </strong>The scarce literature available on the association between the use of mesalazine and increased risk of lithiasis fails to provide frequency data. Only a previous case on mesalazine crystalluria had been reported in the literature so far, probably due to the difficulty detecting this complication. This case series emphasizes the role of urine sediment analysis in identifying crystalluria and preventing major complications during the follow-up of patients receiving mesalazine therapy.</p>","PeriodicalId":72097,"journal":{"name":"Advances in laboratory medicine","volume":"6 4","pages":"492-495"},"PeriodicalIF":1.1,"publicationDate":"2025-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12744377/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145859552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Utilidad del PSA en vesículas extracelulares como biomarcador de seguimiento en el cáncer de próstata. PSA作为前列腺癌随访生物标志物在细胞外囊泡中的应用。
IF 1.1 Q4 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2025-11-04 eCollection Date: 2025-12-01 DOI: 10.1515/almed-2025-0159
Amaia Sandúa, José L Pérez-Gracia, Estibaliz Alegre, Álvaro González
{"title":"Utilidad del PSA en vesículas extracelulares como biomarcador de seguimiento en el cáncer de próstata.","authors":"Amaia Sandúa, José L Pérez-Gracia, Estibaliz Alegre, Álvaro González","doi":"10.1515/almed-2025-0159","DOIUrl":"10.1515/almed-2025-0159","url":null,"abstract":"","PeriodicalId":72097,"journal":{"name":"Advances in laboratory medicine","volume":"6 4","pages":"450-457"},"PeriodicalIF":1.1,"publicationDate":"2025-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12744381/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145859564","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Advances in laboratory medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1